Assay of active pharmaceutical ingredients in drug products based on relative response factors: Instrumentation insights and practical considerations

被引:0
|
作者
Liu, Lisa [1 ]
Mouallem, Ariel [1 ]
Xiao, Kang Ping [1 ]
Meisel, Jerry [1 ]
机构
[1] Bayer Consumer Hlth, Global R&D Prod Dev Ctr, Morristown, NJ 07960 USA
关键词
HPLC relative response factor (RRF); Potency assay; Slit width; Step width; Band width; 3D/2D data collection module; PERFORMANCE LIQUID-CHROMATOGRAPHY; REFERENCE-STANDARD; MULTI-COMPONENTS; ULTRAVIOLET; RUGGEDNESS; IMPURITIES;
D O I
暂无
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Relative Response Factors (RRFs) can be used for quantitation of one compound against another and it is widely used for Impurity analysis of pharmaceutical products; however, the application in potency assay is limited. Through an extensive study shown in this paper, it can be concluded that using the "RRF methodology" for potency assay is much more challenging compared to impurity analysis, due to the much tighter criteria required for potency analysis. The effects of instrument settings, which are rarely discussed or recognized in current HPLC analytical method development and quality release testing, are discussed. These factors impact the RRF just as much as other commonly recognized HPLC parameters. The effects of UV detector settings, i.e. Slit Width, Step Width, Band Width, and Data Collection Module, have been explored. This phenomenon has been demonstrated using three compounds to observe the impact of their quantitation due to the significant RRF variations. Finally, principles to reduce RRF variations have been discussed, and practical considerations of RRF application to method development and method transfer are provided. (C) 2020 The Authors. Published by Elsevier B.V.
引用
收藏
页数:13
相关论文
共 28 条
  • [1] Assay of active pharmaceutical ingredients in drug products based on relative response factors: Instrumentation insights and practical considerations
    Liu, Lisa
    Mouallem, Ariel
    Xiao, Kang Ping
    Meisel, Jerry
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021, 194
  • [2] Impurities in Drug Products and Active Pharmaceutical Ingredients
    Katny, M.
    Frankowski, M.
    CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY, 2017, 47 (03) : 187 - 193
  • [3] FDA inspections of drug products and active pharmaceutical ingredients
    Kirrstetter, R
    PHARMAZEUTISCHE INDUSTRIE, 2004, 66 (10): : 1260 - +
  • [4] The role of degradant profiling in active pharmaceutical ingredients and drug products
    Alsante, Karen M.
    Ando, Akemi
    Brown, Roland
    Ensing, Janice
    Hatajik, Todd D.
    Kong, Wei
    Tsuda, Yoshiko
    ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (01) : 29 - 37
  • [5] Impurities in Active Pharmaceutical Ingredients and Drug Products: A Critical Review
    Cordeiro, Cleydson Finotti
    Franco, Lucas Lopardi
    Carvalho, Diogo Teixeira
    Bonfilio, Rudy
    CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY, 2024,
  • [6] Editorial: Medicinal chemistry of active pharmaceutical ingredients of drug products
    Imran, Mohd
    Alhadidi, Qasim M.
    Khan, Shah Alam
    Khamees Thabet, Hamdy
    Alam, Ozair
    Shakeel, Faiyaz
    Rahman, Ziyaur
    Amjad, Muhammad Wahab
    FRONTIERS IN CHEMISTRY, 2024, 12
  • [7] Designing greener active pharmaceutical ingredients: Insights from pharmaceutical industry into drug discovery and development
    Puhlmann, Neele
    Vidaurre, Rodrigo
    Kuemmerer, Klaus
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 192
  • [8] Active pharmaceutical ingredients based on salicylate ionic liquids: insights into the evaluation of pharmaceutical profiles
    Pinto, Paula C. A. G.
    Ribeiro, Diogo M. G. P.
    Azevedo, Ana M. O.
    Dela Justina, Vanessa
    Cunha, E.
    Bica, K.
    Vasiloiu, M.
    Reis, Salette
    Saraiva, M. Lucia M. F. S.
    NEW JOURNAL OF CHEMISTRY, 2013, 37 (12) : 4095 - 4102
  • [9] Analytical approaches for the detection of epoxides and hydroperoxides in active pharmaceutical ingredients, drug products and herbals
    Elder, D. P.
    Snodin, D.
    Teasdale, A.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, 51 (05) : 1015 - 1023
  • [10] Sample preparation optimization for assay of active pharmaceutical ingredients in a transdermal drug delivery system using experimental designs
    Li, WY
    Nadig, D
    Rasmussen, HT
    Patel, K
    Shah, T
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 37 (03) : 493 - 498